NCT00650520 - Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Healthy

Interventions

DRUG

BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg

4x2.5mg bromocriptine mesylate, single dose fed; with 10mg metoclopramide HCl prophylactic injection

DRUG

Parlodel® (bromocriptine mesylate) capsules, USP 5 mg

4x2.5mg bromocriptine mesylate, single dose fed; with 10mg metoclopramide HCl prophylactic injection

Trial Locations (1)

MDS Pharma Services, Montreal